416 related articles for article (PubMed ID: 31925912)
21. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA HOTTIP promotes prostate cancer cells proliferation and migration by sponging
Yang B; Gao G; Wang Z; Sun D; Wei X; Ma Y; Ding Y
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29884766
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
Li C; Wan L; Liu Z; Xu G; Wang S; Su Z; Zhang Y; Zhang C; Liu X; Lei Z; Zhang HT
Cancer Lett; 2018 Apr; 418():185-195. PubMed ID: 29339211
[TBL] [Abstract][Full Text] [Related]
25. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
[TBL] [Abstract][Full Text] [Related]
26. MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Tong X; Wang S; Lei Z; Li C; Zhang C; Su Z; Liu X; Zhao J; Zhang HT
Oncogene; 2020 Apr; 39(14):2890-2904. PubMed ID: 32029901
[TBL] [Abstract][Full Text] [Related]
27. miR-15a/miR-16 cluster inhibits invasion of prostate cancer cells by suppressing TGF-β signaling pathway.
Jin W; Chen F; Wang K; Song Y; Fei X; Wu B
Biomed Pharmacother; 2018 Aug; 104():637-644. PubMed ID: 29803177
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation a TGF-β-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method.
Huang T; Huang W; Lu H; Zhang BY; Ma J; Zhao D; Wang YJ; Yu DH; He X
J Transl Med; 2018 Feb; 16(1):46. PubMed ID: 29490660
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
30. Elf5 inhibits TGF-β-driven epithelial-mesenchymal transition in prostate cancer by repressing SMAD3 activation.
Yao B; Zhao J; Li Y; Li H; Hu Z; Pan P; Zhang Y; Du E; Liu R; Xu Y
Prostate; 2015 Jun; 75(8):872-82. PubMed ID: 25728398
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits migration and invasion through Epithelial-Mesenchymal-Transition in lung cancer.
Hao Y; Yang X; Zhang D; Luo J; Chen R
Gene; 2017 Apr; 608():1-12. PubMed ID: 28119085
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of LncRNA SNHG7 inhibited epithelial-mesenchymal transition in prostate cancer though miR-324-3p/WNT2B axis in vitro.
Han Y; Hu H; Zhou J
Pathol Res Pract; 2019 Oct; 215(10):152537. PubMed ID: 31324390
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
[TBL] [Abstract][Full Text] [Related]
35. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness.
Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T
Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978
[TBL] [Abstract][Full Text] [Related]
36. TGF-β-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12.
Fan Y; Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y
Clin Cancer Res; 2014 Mar; 20(6):1531-41. PubMed ID: 24449823
[TBL] [Abstract][Full Text] [Related]
37. LncRNA PVT1 promotes proliferation and invasion through enhancing Smad3 expression by sponging miR-140-5p in cervical cancer.
Chang QQ; Chen CY; Chen Z; Chang S
Radiol Oncol; 2019 Oct; 53(4):443-452. PubMed ID: 31626590
[TBL] [Abstract][Full Text] [Related]
38. LncRNA UCA1 acts as a sponge of miR-204 to up-regulate CXCR4 expression and promote prostate cancer progression.
He C; Lu X; Yang F; Qin L; Guo Z; Sun Y; Wu J
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30940776
[TBL] [Abstract][Full Text] [Related]
39. LncRNA PCAT6 promotes tumor progression in osteosarcoma via activation of TGF-β pathway by sponging miR-185-5p.
Zhu C; Huang L; Xu F; Li P; Li P; Hu F
Biochem Biophys Res Commun; 2020 Jan; 521(2):463-470. PubMed ID: 31676070
[TBL] [Abstract][Full Text] [Related]
40. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
